Mastek (MASTEK) Q4 05/06 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 05/06 earnings summary
26 Oct, 2026Executive summary
FY06 revenue rose 22% to Rs 7.011bn and net profit increased 29% to Rs 691m; EBITDA margin improved to 19% from 17%.
The strategy narrowed new-business focus to government and insurance while growing strategic accounts; repeat business generated over 90% of revenue.
Financial highlights
Consolidated income was Rs 7.011bn vs Rs 5.766bn; operating profit was Rs 1.312bn vs Rs 980m, and profit before tax was Rs 1.012bn vs Rs 725m.
Net profit was Rs 691m vs Rs 534m; reported net margin was 10% vs 9%, and basic EPS was Rs 24.76 vs Rs 19.20, adjusted for the 1:1 bonus issue.
Operating cash flow reached Rs 888m vs Rs 780m; cash and cash equivalents including liquid investments were Rs 1.482bn vs Rs 1.106bn.
Outlook and guidance
Management expected robust insurance growth and dominant share over the next 2–3 years, supported by Elixir, Capita's platform selection and Zurich Insurance business.
FY07 growth outlook cited a healthy order backlog/pipeline, strategic positioning and partnerships; NASSCOM projected Indian IT-ITES export growth of ~28%.
US state and local government bids were expected to produce potential deals in the following financial year, reflecting long sales lead times.
Latest events from Mastek
- FY24 revenue and backlog grew, while operating margins narrowed and FY25 priorities sharpened.MASTEK
Q4 23/24 - 45% consolidated revenue growth was offset by Asia Pacific losses and exceptional charges.MASTEK
Q4 97/98 - Revenue rose 65%, led by US and Europe, while receivables and regional weakness weighed on execution.MASTEK
Q4 98/99 - Revenue rose 53% and profit 205%, while a major US client reduction pressured Q4 results.MASTEK
Q4 99/00 - Revenue growth slowed to 3% as profits fell; Europe offset US weakness.MASTEK
Q4 00/01 - Revenue rose 12%, profits surged, and strategic accounts offset a difficult IT market.MASTEK
Q4 01/02 - Revenue rose 30%, while utilization and selling costs squeezed operating margins.MASTEK
Q4 02/03 - Revenue grew 8%, profits fell, and a record backlog strengthened the FY05 outlook.MASTEK
Q4 03/04 - Record FY05 profit growth, led by UK strength and insurance expansion.MASTEK
Q4 04/05